We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.09 | 2.73% | 3.39 | 3.00 | 3.78 | 17,740 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.33 | 9.74M |
TIDMPRM
RNS Number : 2266E
Proteome Sciences PLC
04 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Proteome Sciences PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- -------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ---------------------------------------------------------------- ----------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- ----------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- ----------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------- ----------------------------------- Other (please specify): --------------------------------------------------------- ----- ----------------------------------- 3. Full name of person(s) Lombard Odier Asset Management subject to the (Europe) Limited notification obligation: (iii) ----------------------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) Disclosure on behalf of accounts (if different from 3.):(iv) managed on a discretionary basis by Lombard Odier Investment Managers group. ----------------------------------------------------------- ---------------------------------------- 5. Date of the transaction 27/04/2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ---------------------------------------- 6. Date on which issuer 04/05/2017 notified: ----------------------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are Below 5% crossed or reached: (vi, vii) ----------------------------------------------------------- ---------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ----------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------- -------------- --------- ------------ ------------ ----------- GB0003104196 14,925,249 14,925,249 14,725,249 4.99% ---------------- ----------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- --------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- --------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- -------------- --------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 14,725,249 4.99 % ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ----------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ----------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ----------------- 13. Additional information: ------------------------------------------------------------- ----------------- 14. Contact name: Kiran Bassi ------------------------------------------------------------- ----------------- 15. Contact telephone number: +44 20 3206 6000 ------------------------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUUPAUPMGWC
(END) Dow Jones Newswires
May 04, 2017 09:23 ET (13:23 GMT)
1 Year Proteome Sciences Chart |
1 Month Proteome Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions